相关实验视频
Updated: Jan 17, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
909
除了肥胖之外的其他问题
1Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
Medical sciences (Basel, Switzerland)
|September 22, 2025
概括
建议对肥胖进行新的诊断类别,包括"临床前肥胖". 这旨在通过考虑脂肪的分布和功能来改善诊断,而不仅仅是身体质量指数 (BMI),可能会使用诸如"肥胖"等术语.
科学领域:
- 医学诊断 医学诊断 医学诊断
- 公共卫生 公共卫生
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 肥胖诊断已经从生命保险表演变为身体质量指数 (BMI).
- 体重指数有局限性,肥胖流行需要改进的诊断工具.
- 脂肪的分布和功能是肥胖的关键方面,由Jean Vague率先提出.
研究的目的:
- 讨论关于增加体脂和异常分布的改进诊断方法.
- 探索肥胖的替代术语,例如脂肪或健康体重.
- 解决当前肥胖诊断标准的局限性和需要新的指导方针.
主要方法:
- 对肥胖的历史诊断标准的审查.
- 讨论身体质量指数 (BMI) 的限制.
- 探索脂肪分布和功能在肥胖中的作用.
主要成果:
- 关于一个新的诊断类别"临床前肥胖"的建议.
- 突出需要诊断指南超越BMI.
- 确定"肥胖"和"健康体重"作为潜在的替代术语.
结论:
- 目前用于肥胖的诊断方法,主要是BMI,是不够的.
- 需要新的诊断指南来解释脂肪的分布和功能.
- 像"肥胖"这样的替代术语可能会减少与肥胖相关的耻辱.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Binge Eating Disorders
426
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
426
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Bulimia Nervosa
692
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
692

